期刊文献+

免疫抑制剂血药浓度与肾移植术后腹泻的关联性分析 被引量:6

Association analysis of plasma concentration of immunosuppressants with occurrence of diarrhea in renal transplant recipients
下载PDF
导出
摘要 目的探讨免疫抑制剂霉酚酸酯(MMF)、他克莫司(FK506)血药浓度与肾移植术后腹泻之间的关系。方法选取2015年8月至2017年8月在安徽医科大学第一附属医院行肾移植手术的146例受者,根据术后是否发生腹泻分为两组,未发生腹泻的患者为非腹泻组(83例)、发生腹泻且大于1次者为腹泻组(63例),测定受者的霉酚酸谷浓度(MPA-C_0)和FK506谷浓度(FK506-C_0),记录术后出现的腹泻情况,运用统计软件分析MPA-C_0和FK506-C_0与腹泻间的关系。结果腹泻组与非腹泻组之间MPA-C_0差异无统计学意义(P> 0. 05),FK506-C_0差异有统计学意(P <0. 001); ROC曲线分析显示,FK506-C_0仅在术后1个月差异有统计学意义(曲线下面积0. 607,P <0. 05),FK506 C_0<11. 15 ng/mL是术后1个月发生腹泻的截断值,敏感度51. 90%,特异性63. 60%; MPA-C_0与FK506-C_0对腹泻发生不存在交互作用(P> 0. 05)。结论 MPA-C_0与腹泻的发生没有关联性,而较高的FK506-C_0易导致肾移植术后腹泻,其中术后1个月FK506-C_0<11. 15 ng/mL是发生腹泻的的最佳截断值。 Objective To explore the relationship between plasma concentration of mycophenolatemofetil( MMF) and tacrolimus( FK506) and diarrhea after renal transplantation. Methods The 146 patients,who underwent kidney transplantation inthe First Affiliated Hospital of Anhui Medical University from Aug 2015 to Aug 2017,were divided into two groups( diarrhea group and non-diarrhea group).By measuring the plasma concentration of MPA and FK506 in the recipients,the occurrence of diarrhea after medication was recorded. Statistical software was used to analyze the association between MPA-C0 and FK506-C0 and the occurrence of diarrhea. Results There were no significant differences between MPA-C0 of two groups with orwithout diarrhea( P > 0. 05). However,it was observed that FK506-C0 difference between the two group was statistically significant( P > 0. 05). According to ROC curve,the AUC of theROC curve of FK506-C0 to diagnose the occurrence of diarrhea 1 month after transplantationwas 0. 607( P < 0. 05). FK506-C0 less than 11. 15 ng/mL 1 month after surgery was the best cutoff for diarrhea with a sensitivity of 51. 90% and a specificity of 63. 60%. There was no synergistic interaction between MPA-C0 and FK506-C0 on the occurrence of diarrhea( P > 0. 05). Conclusion MPA-C0 has no relationship with the occurrence of diarrhea.However,higher FK506-C0 is more likely to cause diarrhea after renal transplantation,and FK506-C0< 11. 15 ng/mL one month after operation is the best cutoff value for occurrence of diarrhea.
作者 冯丽娟 杨春兰 夏泉 廖贵益 许杜娟 FENG Lijuan;YANG Chunlan;XIA Quan(College of Pharmacy,Anhui Medical University,Hefei 230022,China;Department of Pharmacy,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)
出处 《安徽医学》 2018年第12期1446-1450,共5页 Anhui Medical Journal
基金 北京医卫健康公益基会项目(项目编号:YWJKJJHKYJJ-B16413)
关键词 他克莫司 霉酚酸 肾移植受者 腹泻 血药浓度 Tacrolimus Mycophenolic acid Kidney transplant recipients Diarrhea Plasma concentration
  • 相关文献

参考文献4

二级参考文献38

  • 1贾晋生,武丽娟,李雪琴.抗菌药物相关性腹泻的诊断[J].中华医院感染学杂志,2005,15(8):872-872. 被引量:6
  • 2Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients : results of the DIDACT study [ J ]. Am J Trans- plant, 2006, 6(6) : 1466 - 1472. 被引量:1
  • 3Rubin RH. Gastrointestinal infectious disease complications fol- lowing transplantation and their differentiation from immunosup- pressant-reduced gastrointestinal toxicities [ J ]. Clin Transplant, 2001, 15(Suppl 4) : 11 -22. 被引量:1
  • 4Sellin JH. The pathophysiology of diarrhea [ J ]. Clin Transplant, 2001, 15(Suppl 4) : 2 -10. 被引量:1
  • 5Lee RA, Gabardi S. Current trends in immunosuppressive thera- pies for renal transplant recipients[ J]. Am J Health Syst Pharm, 2012, 69 (22): 1961-1975. 被引量:1
  • 6Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant re- cipients : meta-analysis and meta-regression of randomised trial da- ta[J]. BMJ, 2005, 331(7520): 810-886. 被引量:1
  • 7Flechner SM, Glyda M, Cockfield S, et al. The ORION study: comparison of two sirolimus based regimens versus taerolimus and mycophenolate mofetil in renal allograft trcipients [ J ]. Am J Transplant, 2011, 11 : 1633 - 1644. 被引量:1
  • 8HellerT, van Gelder T, Budde K, et al. Plasma concentrations of mycophenolie acid aeylglueuronide are no tassoeiated with diarrhea in renal transplant recipients [J]. Am J Transplant, 2007, 7 (7) : 1822 -1831. 被引量:1
  • 9Tierce JC, Porterfield-Baxa J, Petrilla AA, et al. Impact of myco- phenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients[J].Clin Transplant, 2005, 19 (6) : 779 -784. 被引量:1
  • 10Hardinger KL, Hebbar S, Bloomer T, et al. Adverse drug reaction driven immunosuppressive drug manipulations: A single-center comparison of enteric-coated mycophenolate sodium vs. mycophe- nolate mofetil[ J]. Clin Transolant, 2008, 22(5): 555- 561. 被引量:1

共引文献154

同被引文献61

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部